Log in

NASDAQ:LNTH - Lantheus Stock Price, Forecast & News

$16.57
0.00 (0.00 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$16.22
Now: $16.57
$16.60
50-Day Range
$16.53
MA: $17.98
$20.06
52-Week Range
$16.05
Now: $16.57
$29.80
Volume484,260 shs
Average Volume296,484 shs
Market Capitalization$650.37 million
P/E Ratio19.05
Dividend YieldN/A
Beta1.43
Lantheus Holdings, Inc develops, manufactures, and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases worldwide. Its principal products include DEFINITY, a microbubble contrast agent used in ultrasound exams of the heart; and TechneLite, a technetium generator that provides the nuclear material used in nuclear medicine procedures. Read More…

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:LNTH
CUSIPN/A
Phone978-671-8001

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$343.37 million
Cash Flow$1.36 per share
Book Value$1.85 per share

Profitability

Net Income$40.51 million

Miscellaneous

Employees488
Market Cap$650.37 million
Next Earnings Date2/25/2020 (Confirmed)
OptionableOptionable

Receive LNTH News and Ratings via Email

Sign-up to receive the latest news and ratings for LNTH and its competitors with MarketBeat's FREE daily newsletter.


Lantheus (NASDAQ:LNTH) Frequently Asked Questions

What is Lantheus' stock symbol?

Lantheus trades on the NASDAQ under the ticker symbol "LNTH."

How were Lantheus' earnings last quarter?

Lantheus Holdings Inc (NASDAQ:LNTH) posted its earnings results on Thursday, October, 31st. The medical equipment provider reported $0.28 EPS for the quarter, beating the Zacks' consensus estimate of $0.21 by $0.07. The medical equipment provider earned $85.80 million during the quarter, compared to analysts' expectations of $83.82 million. Lantheus had a net margin of 10.02% and a return on equity of 46.58%. Lantheus's revenue for the quarter was down 3.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.24 earnings per share. View Lantheus' Earnings History.

When is Lantheus' next earnings date?

Lantheus is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Lantheus.

How can I listen to Lantheus' earnings call?

Lantheus will be holding an earnings conference call on Tuesday, February 25th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What is the consensus analysts' recommendation for Lantheus?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lantheus in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Lantheus.

Has Lantheus been receiving favorable news coverage?

Press coverage about LNTH stock has trended negative on Saturday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Lantheus earned a daily sentiment score of -2.0 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for Lantheus.

Are investors shorting Lantheus?

Lantheus saw a increase in short interest during the month of January. As of January 15th, there was short interest totalling 1,400,000 shares, an increase of 14.8% from the December 31st total of 1,220,000 shares. Based on an average trading volume of 360,700 shares, the short-interest ratio is currently 3.9 days. Approximately 3.7% of the company's shares are short sold. View Lantheus' Current Options Chain.

Who are some of Lantheus' key competitors?

What other stocks do shareholders of Lantheus own?

Who are Lantheus' key executives?

Lantheus' management team includes the folowing people:
  • Ms. Mary Anne Heino, CEO, Pres & Director (Age 59)
  • Mr. Robert J. Marshall Jr., CFO & Treasurer (Age 52)
  • Mr. Michael P. Duffy, Sr. VP of Law & Public Policy, Gen. Counsel and Sec. (Age 58)
  • Dr. Cesare Orlandi, Chief Medical Officer (Age 69)
  • Mr. John J. Bolla, Chief Operating Officer (Age 49)

When did Lantheus IPO?

(LNTH) raised $75 million in an initial public offering on Thursday, June 25th 2015. The company issued 7,900,000 shares at $8.50-$10.50 per share. Citigroup, Jefferies, RBC Capital Markets and Wells Fargo Securities acted as the underwriters for the IPO and Baird was co-manager.

Who are Lantheus' major shareholders?

Lantheus' stock is owned by many different of institutional and retail investors. Top institutional investors include State Street Corp (3.76%), Renaissance Technologies LLC (3.58%), Vaughan Nelson Investment Management L.P. (3.38%), LSV Asset Management (3.25%), Tamarack Advisers LP (1.66%) and Prudential Financial Inc. (1.61%). Company insiders that own Lantheus stock include A Frederick Robertson, Brian A Markison, Cesare Orlandi, Derace L Schaffer, John J Bolla, Julie Mchugh, Mary Anne Heino, Michael P Duffy, Robert J Jr Marshall, Sam R Leno, Timothy G Healey and Tudor Brown. View Institutional Ownership Trends for Lantheus.

Which major investors are selling Lantheus stock?

LNTH stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Rice Hall James & Associates LLC, Renaissance Technologies LLC, Royce & Associates LP, Citigroup Inc., Tamarack Advisers LP, Alliancebernstein L.P. and AQR Capital Management LLC. Company insiders that have sold Lantheus company stock in the last year include A Frederick Robertson, Brian A Markison, Cesare Orlandi, Derace L Schaffer, John J Bolla, Mary Anne Heino, Michael P Duffy, Robert J Jr Marshall, Sam R Leno and Tudor Brown. View Insider Buying and Selling for Lantheus.

Which major investors are buying Lantheus stock?

LNTH stock was purchased by a variety of institutional investors in the last quarter, including Broadfin Capital LLC, Russell Investments Group Ltd., Bank of Montreal Can, Prudential Financial Inc., Public Sector Pension Investment Board, Geode Capital Management LLC, First Trust Advisors LP and Great West Life Assurance Co. Can. View Insider Buying and Selling for Lantheus.

How do I buy shares of Lantheus?

Shares of LNTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Lantheus' stock price today?

One share of LNTH stock can currently be purchased for approximately $16.57.

How big of a company is Lantheus?

Lantheus has a market capitalization of $650.37 million and generates $343.37 million in revenue each year. The medical equipment provider earns $40.51 million in net income (profit) each year or $0.94 on an earnings per share basis. Lantheus employs 488 workers across the globe.View Additional Information About Lantheus.

What is Lantheus' official website?

The official website for Lantheus is http://www.lantheus.com/.

How can I contact Lantheus?

Lantheus' mailing address is 331 TREBLE COVE ROAD, NORTH BILLERICA MA, 01862. The medical equipment provider can be reached via phone at 978-671-8001 or via email at [email protected]


MarketBeat Community Rating for Lantheus (NASDAQ LNTH)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  271 (Vote Outperform)
Underperform Votes:  258 (Vote Underperform)
Total Votes:  529
MarketBeat's community ratings are surveys of what our community members think about Lantheus and other stocks. Vote "Outperform" if you believe LNTH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LNTH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Featured Article: Profit Margin

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel